Correction
Dong Mei, Binlong Chen, Bing He, Haibin Liu, Zhiqiang Lin, Jialiang Lin, Xiaoyan Zhang, Ning Sun, Libo Zhao, Xiaoling Wang, Qiang Zhang. Author correction to ‘Actively priming autophagic cell death with novel transferrin receptor-targeted nanomedicine for synergistic chemotherapy against breast cancer’ [Acta Pharmaceutica Sinica B 2019; 9(5): 1061-1077][J]. Acta Pharmaceutica Sinica B, 2020, 10(6): 1143-1144

Author correction to ‘Actively priming autophagic cell death with novel transferrin receptor-targeted nanomedicine for synergistic chemotherapy against breast cancer’ [Acta Pharmaceutica Sinica B 2019; 9(5): 1061-1077]
Dong Meia,b, Binlong Chenb, Bing Heb, Haibin Liuc, Zhiqiang Lind, Jialiang Linb, Xiaoyan Zhanga, Ning Suna, Libo Zhaoa, Xiaoling Wanga, Qiang Zhangb
a Clinical Research Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing 100045, China;
b Key Laboratory of Molecular Pharmaceutics, New Drug Delivery Systems, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China;
c Department of General Surgery, ChinaeJapan Friendship Hospital, Beijing 100029, China;
d Institute of Systems Biomedicine, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China
Abstract:
Key words:   
Received:     Revised:
DOI: 10.1016/j.apsb.2020.03.003
Corresponding author: Xiaoling Wang, Qiang Zhang     Email:eyjdb6380@163.com;zqdodo@bjmu.edu.cn
Author description:
Service
PDF(KB) Free
Print
0
Authors
Similar articles: